2.26
price down icon1.31%   -0.03
after-market Handel nachbörslich: 2.27 0.01 +0.44%
loading

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
54.85%
-3.597
-7.966 -10.94 -13.92 -10.55
Nonoperating Income/Loss
10.42%
0.086
0.096 0.076 0.105 -0.005
Income/Loss From Continuing Operations Before Tax
55.39%
-3.511
-7.87 -10.86 -13.81 -10.56
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
55.39%
-3.511
-7.87 -10.86 -13.81 -10.56
Net Income/Loss
55.39%
-3.511
-7.87 -10.86 -13.81 -10.56
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.75%
4.4401
3.803 3.4377 4.3643 25.81
Diluted Average Shares
16.75%
4.4401
3.803 3.4377 4.3643 25.81
Basic Earnings Per Share
61.84%
-0.79
-2.07 -3.16 -0.31 -0.41
Diluted Earnings Per Share
61.84%
-0.79
-2.07 -3.16 -0.31 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):